Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

45.65p
   
  • Change Today:
    -0.100p
  • 52 Week High: 49.55p
  • 52 Week Low: 29.35p
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 678,755
  • Market Cap: £246.77m
  • RiskGrade: 119
  • Beta: 0.95

Latest ShareCast News

Revenue, profits rise for Alliance Pharma

By Josh White

Date: Monday 30 Sep 2024

(Sharecast News) - Alliance Pharma reported a 2.8% increase in revenue on Monday, to £84.8m on a see-through basis, driven by the robust performance of its Kelo-Cote franchise.

Alliance Pharma ShareCast News

Alliance Pharma flags solid rise in first-half r... 29-Jul-2024 ShareCast
Alliance Pharma COO stepping down, position to b... 23-Jul-2024 ShareCast
Alliance Pharma posts strong results after audit... 19-Jun-2024 ShareCast
Butterfield out, Sedgwick in as Alliance Pharma ... 08-May-2024 ShareCast
Alliance Pharma delays preliminary results 22-Apr-2024 ShareCast

Alliance Pharma Regulatory News

Block Listing Six Monthly Return 30-Dec-2024 17:21 RNS
Notification of Major Holdings 10-Oct-2024 18:11 RNS
Interim Results 30-Sep-2024 07:00 RNS
Notification of Half Year Results 12-Sep-2024 07:00 RNS
Result of AGM 29-Jul-2024 16:10 RNS

Alliance Pharma Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Alliance Pharma Tips & Analysis

Investment Column : Alliance Pharma 09-Sep-2010 The Independent
Investment Column:Alliance Pharma 19-Mar-2009 The Independent
Market report: Thursday latest 13-Sep-2007 Daily Mail
Gloomy summer casts shadow over Next 10-Sep-2007 The Independent

Alliance Pharma News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 45.65p
Change Today -0.100p
% Change -0.22 %
52 Week High 49.55p
52 Week Low 29.35p
Volume 678,755
Shares Issued 540.57m
Market Cap £246.77m
Beta 0.95
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.17% below the market average12.17% below the market average12.17% below the market average12.17% below the market average12.17% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
48.60% above the market average48.60% above the market average48.60% above the market average48.60% above the market average48.60% above the market average
67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average
Income Not Available
Growth
38.67% below the market average38.67% below the market average38.67% below the market average38.67% below the market average38.67% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 02-Jan-2025

Time Volume / Share Price
15:39 12 @ 45.56p
15:23 3,250 @ 45.70p
15:06 2,641 @ 45.80p
15:00 38,193 @ 45.37p
14:52 5 @ 45.27p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page